PAYER POLICY CHANGES

J0593 Insurance Policy Changes

HCPCS J0593 is officially defined as "Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)." HCPCS J0593 is referenced in 5 tracked payer policy changes from Blue Cross & Blue Shield of Mississippi, Aetna, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0593 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J0593

Get one email when a payer policy names J0593, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J0593

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J0593 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.